RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics, Inc. (http://www.talecris.com) announced today that all new releases of Gamunex® (Immune Globulin Intravenous (Human), 10%, Caprylate/Chromatography Purified) in the United States are latex-free. With the elimination of latex from the rubber stoppers used in the product packaging, physicians can confidently use Gamunex in their patients with latex allergy. Furthermore, the product enhancement for Gamunex demonstrates the Talecris effort to recognize and respond to the growing healthcare trend to establish entire medical environments as “latex-free.”
